jade101

jade101: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.

Development Pipeline (1)

Clinical Trials (1)

A Phase 1, Randomized, Double-blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JADE101 Administered Subcutaneously in Healthy Volunteers

NCT07059312·Phase 1·JBIO

Frequently asked questions

Who is developing jade101?

jade101 is being developed by Jade Biosciences, Inc..

How many clinical trials involve jade101?

BioSniper tracks 1 clinical trial involving jade101.

Get deeper analysis on jade101

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    jade101 — Drug Pipeline, Trials & FDA Status | BioSniper